Ask AI

Lung Cancer

Share

Program Content

Activities

LIBRETTO-432
LIBRETTO-432: Phase III Trial of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion–Positive NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 15, 2026

Supporters

This activity is supported by educational grants from Lilly and PharmaMar.

Lilly

PharmaMar